Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.

Sethi TK, Basdag B, Bhatia N, Moslehi J, Reddy NM
Curr Hematol Malig Rep. 2017 12 (3): 257-267

PMID: 28233150 · DOI:10.1007/s11899-017-0369-y

MeSH Terms (11)

Animals Anthracyclines Antineoplastic Agents Cardiotoxicity Cardiovascular Diseases Disease Management Drug Evaluation, Preclinical Hematologic Neoplasms Humans Molecular Targeted Therapy Protein Kinase Inhibitors

Connections (1)

This publication is referenced by other Labnodes entities: